Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04141761
PHASE2

Probiotics in Newly Diagnosed T1D

Sponsor: Medical College of Wisconsin

View on ClinicalTrials.gov

Summary

The investigators aim to further the understanding of environmental factors that underlie the development of Type 1 diabetes (T1D) and the post-onset disease trajectory. Dysbiosis, defined as alterations in intestinal microbiota composition and function, has been hypothesized to increase the risk of developing T1D in those with genetic susceptibility. Dysbiosis may result from modern dietary habits, such as broad consumption of the highly processed Western Diet, or by widespread use of antibiotics. Here, the investigators propose to examine the impact of dysbiosis on the endogenous innate inflammatory state that potentiates T1D progression. The investigators hypothesize that probiotic-induced alterations in the intestinal microbiota may favorably alter the post-onset disease state.

Official title: Probiotic-induced Normalization of Innate Inflammation in Youth Newly Diagnosed With Type 1 Diabetes

Key Details

Gender

All

Age Range

5 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

43

Start Date

2019-04-01

Completion Date

2027-06-30

Last Updated

2025-10-16

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Visbiome

This group will receive Visbiome probiotic in powder form.

OTHER

Placebo

This group will receive a placebo in powder form.

Locations (1)

Medical College of Wisconsin

Milwaukee, Wisconsin, United States